Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity

被引:67
作者
Cairns, AP
Crockard, AD
McConnell, JR
Courtney, PA
Bell, AL
机构
[1] Queens Univ Belfast, Musgrave Pk Hosp, Dept Rheumatol, Lupus Res Grp,Musculoskeletal Educ & Res Unit, Belfast BT9 7JB, Antrim, North Ireland
[2] Royal Victoria Hosp, Reg Immunol Serv, Belfast BT12 6BA, Antrim, North Ireland
关键词
D O I
10.1136/ard.60.10.950
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Increased numbers of apoptotic neutrophils, and impaired monocyte/macrophage clearance of apoptotic cells, have been demonstrated in systemic lupus erythematosus (SLE). CD44 is implicated in the clearance of apoptotic neutrophils. Objective-To determine the expression of CD44 on peripheral blood monocytes and neutrophils in SLE, and examine the relations with disease activity and numbers of circulating apoptotic neutrophils. Methods-Peripheral blood was sampled from 31 patients with SLE, 19 healthy normal subjects, and 19 patients with rheumatoid arthritis (RA). Monocyte and neutrophil density of surface CD44 expression was determined by immunofluorescence labelling and flow cytometry, and results expressed as mean channel fluorescence (MCF) values. Neutrophil apoptosis was measured by morphology in 15 patients with SLE, nine with RA, and six normal subjects. Results-Monocyte CD44 expression was significantly lower in SLE (median MCF 4.71) than in healthy normal subjects (median MCF 5.61) and controls with RA (median MCF 5.39). Neutrophil CD44 expression was also significantly lower in SLE (median MCF 1.95) than in healthy normal subjects (median MCF 2.37) and controls with RA (median MCF 2.60). Monocyte, but not neutrophil, CD44 expression correlated negatively with the percentage of apoptotic neutrophils. There was no significant correlation of monocyte or neutrophil CD44 expression in SLE with disease activity or damage. Conclusions-Monocyte and neutrophil CD44 expression is reduced in SLE, and this may contribute to the impaired recognition and clearance of apoptotic neutrophils by monocyte derived macrophages.
引用
收藏
页码:950 / 955
页数:6
相关论文
共 50 条
  • [1] BOBAK DA, 1987, J IMMUNOL, V138, P1150
  • [2] CD44 expression by leucocytes in rheumatoid arthritis and modulation by specific antibody: Implications for lymphocyte adhesion to endothelial cells and synoviocytes in vitro
    Brennan, FR
    Mikecz, K
    Glant, TT
    Jobanputra, P
    Pinder, S
    Bavington, C
    Morrison, P
    Nuki, G
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 45 (02) : 213 - 220
  • [3] VARIATIONS IN THE CYTOSKELETAL INTERACTION AND POSTTRANSLATIONAL MODIFICATION OF THE CD44 HOMING RECEPTOR IN MACROPHAGES
    CAMP, RL
    KRAUS, TA
    PURE, E
    [J]. JOURNAL OF CELL BIOLOGY, 1991, 115 (05) : 1283 - 1292
  • [4] AUTOANTIGENS TARGETED IN SYSTEMIC LUPUS-ERYTHEMATOSUS ARE CLUSTERED IN 2 POPULATIONS OF SURFACE-STRUCTURES ON APOPTOTIC KERATINOCYTES
    CASCIOLAROSEN, LA
    ANHALT, G
    ROSEN, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) : 1317 - 1330
  • [5] Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity
    Courtney, PA
    Crockard, AD
    Williamson, K
    McConnell, J
    Kennedy, RJ
    Bell, AL
    [J]. LUPUS, 1999, 8 (07) : 508 - 513
  • [6] Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia
    Courtney, PA
    Crockard, AD
    Williamson, K
    Irvine, AE
    Kennedy, RJ
    Bell, AL
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (05) : 309 - 314
  • [7] Human CD14 mediates recognition and phagocytosis of apoptotic cells
    Devitt, A
    Moffatt, OD
    Raykundalia, C
    Capra, JD
    Simmons, DL
    Gregory, CD
    [J]. NATURE, 1998, 392 (6675) : 505 - 509
  • [8] DRANSFIELD I, 1996, TECHNIQUES APOPTOSIS, P155
  • [9] Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity
    Estess, P
    DeGrendele, HC
    Pascual, V
    Siegelman, MH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (06) : 1173 - 1182
  • [10] FADOK VA, 1992, J IMMUNOL, V149, P4029